Target intelligence / Profile preview

Blood glucose level regulation

Molecular classification
Other
01

Overview

"Blood glucose level regulation" is **not** the name of a specific molecule, receptor, enzyme, or drug target. Instead, it refers to the complex physiological process by which the body maintains blood sugar within a narrow range. This process involves multiple hormones—primarily **insulin** and **glucagon**, both secreted by the pancreas—as well as various organs such as the liver, muscle tissue, adipose tissue, and kidneys[1][2][3][5]. Insulin lowers blood glucose by promoting cellular uptake and storage as glycogen or fat; glucagon raises it by stimulating glycogen breakdown in the liver[1][3]. Additional regulatory factors include somatostatin from pancreatic delta cells[1]. The molecular effectors involved in this system include hormone receptors (e.g., insulin receptor), enzymes involved in glycogen metabolism, and several classes of glucose transporters such as GLUT1–4 and SGLT proteins[2]. Drugs that interact with these pathways include exogenous insulin preparations for diabetes management or glucagon injections for severe hypoglycemia[3]. Because "blood glucose level regulation" describes an entire physiological pathway rather than an individual molecular entity or therapeutic target, it should not be considered a canonical drug target. For structured data purposes—such as those used in pharmacology databases—the correct approach would be to specify one of its key components like "Insulin receptor," "Glucagon receptor," "Sodium-glucose cotransporter 2," etc., depending on context. In summary: **Blood glucose level regulation is not itself a molecule or therapeutic target but rather describes an essential metabolic control system involving many targets.** If you need information about specific molecules within this pathway—such as insulin receptor or glucagon-like peptide 1 receptor—please specify which component you are interested in.[1][2][3]

Other names
Blood glucose regulationBlood sugar regulationGlucose homeostasis
02

Mechanism of action

The process involves insulin lowering blood glucose by promoting cellular uptake and storage as glycogen or fat, and glucagon raising it by stimulating glycogen breakdown in the liver.

03

Biological functions

Metabolic homeostasisEnergy balanceRegulation of blood glucose concentration
04

Disease associations

Diabetes mellitus (type 1 and type 2)HypoglycemiaHyperglycemiaMetabolic syndrome
05

Interacting drugs

exogenous insulin preparations

1 more in the full profile.

06

Biomarkers

blood glucose

Beyond the preview

Go deeper on Blood glucose level regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood glucose level regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call